A 32-year-old man with sickle cell disease presents with acute chest syndrome (fever, chest pain, pulmonary infiltrate). Which agent is the first-line treatment to reduce mortality and organ damage in this life-threatening complication?

Question

Accepted Answer

A. Exchange transfusion. ## Acute Chest Syndrome: First-Line Management **Key Point:** Exchange transfusion (erythrocytapheresis) is the gold-standard intervention for acute chest syndrome (ACS) in sickle cell disease, reducing mortality from ~10% to <5% when performed early. ### Definition & Pathophysiology of ACS Acute chest syndrome is defined by: - New pulmonary infiltrate on imaging (CXR/CT) - Fever, chest pain, dyspnea, or hypoxia - Occurs in ~25% of sickle cell patients at some point - Can progress to acute respiratory distress syndrome (ARDS) and death **High-Yield:** ACS is caused by: 1. Vaso-occlusion of pulmonary vessels 2. Fat embolism from bone marrow infarction 3. Infection (bacterial or viral) 4. In situ thrombosis ### Exchange Transfusion: Mechanism & Evidence **Clinical Pearl:** Exchange transfusion works by: - Rapidly reducing HbS percentage to <30% (target) - Improving microvascular flow and oxygenation - Reducing hemolysis and inflammatory mediators - Preventing multi-organ failure | Intervention | Mortality Reduction | Timing | Evidence | |---|---|---|---| | Exchange transfusion | 10% → <5% | Within 24–48 hrs | RCTs, ASH guidelines | | Hydroxyurea | Long-term prevention | Chronic use | Not acute management | | Nitric oxide | Adjunctive only | If hypoxia | Limited RCT data | ### Management Algorithm for ACS ```mermaid flowchart TD A[Acute Chest Syndrome diagnosed]:::outcome --> B[Oxygen to target SpO2 >94%]:::action B --> C[Empiric antibiotics]:::action C --> D{Severity?}:::decision D -->|Mild: no hypoxia, single lobe| E[Supportive care + monitor]:::action D -->|Moderate-Severe: hypoxia, multi-lobe| F[Exchange transfusion]:::action F --> G[Reduce HbS to <30%]:::action G --> H[Repeat exchange if worsening]:::action E --> I{Improvement?}:::decision I -->|No| F I -->|Yes| J[Discharge with follow-up]:::outcome ``` ### Supportive Measures (Adjuncts) 1. **Oxygen therapy** — maintain SpO~2~ >94% 2. **Empiric antibiotics** — cover *S. pneumoniae*, *H. influenzae*, *Mycoplasma*, atypical organisms 3. **Analgesia** — opioids for pain control 4. **Incentive spirometry** — prevent atelectasis 5. **Fluid management** — avoid overload (pulmonary edema risk) **Warning:** Do NOT delay exchange transfusion waiting for antibiotics or supportive care alone — mortality increases with delayed intervention. ### Indications for Exchange Transfusion in ACS - Moderate-to-severe disease (hypoxia, multi-lobe infiltrate, hemodynamic instability) - Rapid clinical deterioration - Failure to improve with supportive care within 24 hours - Mild disease may be managed conservatively if improving **Mnemonic:** **EXCHANGE for ACS** = **E**rythrocytapheresis, **X**-ray infiltrate present, **C**ritical oxygenation, **H**emodynamic instability, **A**cute onset, **N**eed rapid reversal, **G**uardian against death, **E**arly intervention saves lives. [cite:Harrison 21e Ch 104; Robbins 10e Ch 14]

Answer

B. Inhaled nitric oxide

Answer

C. Hydroxyurea

Answer

D. Empiric broad-spectrum antibiotics alone

A 32-year-old man with sickle cell disease presents with acute chest syndrome (fever, chest pain, pulmonary infiltrate). Which agent is the first-line treatment to reduce mortality and organ damage in this life-threatening complication?

Explanation

Acute Chest Syndrome: First-Line Management

Definition & Pathophysiology of ACS

Exchange Transfusion: Mechanism & Evidence

Management Algorithm for ACS

Supportive Measures (Adjuncts)

Indications for Exchange Transfusion in ACS

Practice similar questions

Join our NEET PG community

Intervention	Mortality Reduction	Timing	Evidence
Exchange transfusion	10% → <5%	Within 24–48 hrs	RCTs, ASH guidelines
Hydroxyurea	Long-term prevention	Chronic use	Not acute management
Nitric oxide	Adjunctive only	If hypoxia	Limited RCT data